HOME >> BIOLOGY >> NEWS
PET/CT: The best test for women with ovarian cancer

WASHINGTON, D.C.An advanced molecular imaging technique influenced the management of women with ovarian cancer, detected more sites of disease and identified women whose disease was likely to progress, according to an Australian study released during the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

The study shows that positron emission tomography (PET)/computed tomography (CT) imaging "is a much better test for patients with suspected recurrent ovarian cancer and is the preferred imaging technique," said Michael J Fulham, professor and clinical director of Medical Imaging at Sydney South West Area Health Service and head of the Department of PET and Nuclear Medicine at Royal Prince Alfred Hospital in Sydney, Australia.

"PET/CTusing fluorodeoxyglucose or FDGdetected many more sites of disease than were found with routine imaging both within and outside the abdomen," said Fulham in relaying the study's results. "PET/CT influenced treatment decisions in 59 percent of the 90 women and identified those whose disease was more likely to progress within 12 months," he added. "Our findings also suggest that there is an opportunity for technology replacementreplacing routine CT of the abdomen and pelviswith PET/CT with the radiotracer FDG, thus reducing costs and providing better answers for patients and referring doctors," said Fulham.

Ovarian cancercancer that forms in tissues of the ovaryis the leading cause of death in women with gynecologic cancer, noted Fulham. In the United States, reports indicate that more than 22,000 new cases and more than 15,000 deaths attributed to ovarian cancer are expected this year. "Unfortunately, while positive results are possible if the disease is detected early, most women have advanced disease by the time they are first diagnosed," said Fulham.

Initial treatment is surgery followed by chemotherapy. If the cancer recurs, the
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
4-Jun-2007


Page: 1 2 3

Related biology news :

1. Acute sleep deprivation leads to changes in nighttime urine production for men and women
2. Research aims to identify markers for menopausal women at risk for deadly blood clot
3. The female advantage in kidney disease does not extend to diabetic women
4. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
5. New model for autism suggests women carry the disorder and explains age as a risk factor
6. Awards celebrating women and biotech brilliance
7. High blood pressure medication strategy proves effective in Hispanic women
8. Study finds Western-style meat-sweet diet increases risk of breast cancer in postmenopausal women
9. New research shows vaginal bacteria vary among healthy women, need customized treatment
10. Complementary therapy for infertile women may reduce chances of pregnancy
11. Risk-taking in infertility treatment correlates with womens negative moods

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: